Your browser doesn't support javascript.
Downregulated miR-451a as a feature of the plasma cfRNA landscape reveals regulatory networks of IL-6/IL-6R-associated cytokine storms in COVID-19 patients.
Yang, Penghui; Zhao, Yingze; Li, Jie; Liu, Chuanyu; Zhu, Linnan; Zhang, Jie; Yu, Yeya; Wang, Wen-Jing; Lei, Guanglin; Yan, Jin; Sun, Fang; Bian, Chengrong; Meng, Fanping; Xu, Zhe; Bai, Changqing; Ye, Beiwei; Guo, Yuanyuan; Shu, Liumei; Yuan, Xiaoju; Zhang, Ning; Bi, Yuhai; Shi, Yi; Wu, Guizhen; Zhang, Shaogeng; Gao, George F; Liu, Longqi; Liu, William J; Sun, Hai-Xi.
  • Yang P; Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Zhao Y; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Li J; BGI-Shenzhen, Shenzhen, China.
  • Liu C; BGI Education Center, University of Chinese Academic of Sciences, Shenzhen, China.
  • Zhu L; BGI-Shenzhen, Shenzhen, China.
  • Zhang J; Shenzhen Bay Laboratory, Shenzhen, China.
  • Yu Y; BGI-Shenzhen, Shenzhen, China.
  • Wang WJ; Shenzhen Bay Laboratory, Shenzhen, China.
  • Lei G; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Yan J; BGI-Shenzhen, Shenzhen, China.
  • Sun F; BGI College, Zhengzhou University, Zhengzhou, China.
  • Bian C; BGI-Shenzhen, Shenzhen, China.
  • Meng F; Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Xu Z; Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Bai C; Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Ye B; Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Guo Y; Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Shu L; Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Yuan X; Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Zhang N; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Bi Y; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Shi Y; School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, China.
  • Wu G; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zhang S; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Gao GF; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Liu L; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Liu WJ; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Sun HX; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Cell Mol Immunol ; 18(4): 1064-1066, 2021 04.
Article in English | MEDLINE | ID: covidwho-1104476

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interleukin-6 / Receptors, Interleukin-6 / MicroRNAs / Cell-Free Nucleic Acids / Cytokine Release Syndrome / COVID-19 Limits: Humans Language: English Journal: Cell Mol Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: S41423-021-00652-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Interleukin-6 / Receptors, Interleukin-6 / MicroRNAs / Cell-Free Nucleic Acids / Cytokine Release Syndrome / COVID-19 Limits: Humans Language: English Journal: Cell Mol Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: S41423-021-00652-5